Senior insider sale
RVL PHARMACEUTICALS PLC — senior position signals high conviction
$484.2K
4.26M shares
What this filing means
BURGSTAHLER DAVID F plans to sell 4.26M shares of RVL PHARMACEUTICALS PLC valued at approximately $484.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/25/2023ACC: 0001961863-23-000133
Director10% Owner
Since Oct 2018
4.26M
Shares to sell
$484.2K
Approx. market value
670.69K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Private Placement
Private placement
8/8/2022
670.69KTotal acquired670.69K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/8/2022 | Private Placement Private placement | 670.69K | — |
| Total | 670.69K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
160.08K
Market value
$16.0K
8/30/2023
—Completed
Units to sell
879K
Market value
$87.9K
8/30/2023
—Completed
Units to sell
879K
Market value
$87.9K
8/30/2023
—Completed
Units to sell
140.77K
Market value
$17.2K
8/24/2023
—Completed
Units to sell
767.51K
Market value
$107.5K
8/24/2023
—Completed
Units to sell
767.51K
Market value
$107.5K
8/24/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
670.69K
Market value
$60.4K
9/25/2023
Total
Units
4.26M
Value
$484.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/30/2023 | 160.08K | $16.0K | — | Completed |
8/30/2023 | 879K | $87.9K | — | Completed |
8/30/2023 | 879K | $87.9K | — | Completed |
8/24/2023 | 140.77K | $17.2K | — | Completed |
8/24/2023 | 767.51K | $107.5K | — | Completed |
8/24/2023 | 767.51K | $107.5K | — | Completed |
| Planned — Approximate Date | ||||
9/25/2023 | 670.69K | $60.4K | NASDAQ | Planned |
| Total | 4.26M | $484.2K | ||